1. Home
  2. SNPS vs ELV Comparison

SNPS vs ELV Comparison

Compare SNPS & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPS
  • ELV
  • Stock Information
  • Founded
  • SNPS 1986
  • ELV 1944
  • Country
  • SNPS United States
  • ELV United States
  • Employees
  • SNPS 20300
  • ELV N/A
  • Industry
  • SNPS EDP Services
  • ELV Medical Specialities
  • Sector
  • SNPS Technology
  • ELV Health Care
  • Exchange
  • SNPS Nasdaq
  • ELV Nasdaq
  • Market Cap
  • SNPS 86.8B
  • ELV 92.9B
  • IPO Year
  • SNPS 1992
  • ELV N/A
  • Fundamental
  • Price
  • SNPS $565.07
  • ELV $402.56
  • Analyst Decision
  • SNPS Strong Buy
  • ELV Strong Buy
  • Analyst Count
  • SNPS 11
  • ELV 14
  • Target Price
  • SNPS $648.45
  • ELV $543.07
  • AVG Volume (30 Days)
  • SNPS 858.3K
  • ELV 1.9M
  • Earning Date
  • SNPS 12-04-2024
  • ELV 01-22-2025
  • Dividend Yield
  • SNPS N/A
  • ELV 1.62%
  • EPS Growth
  • SNPS 44.58
  • ELV 9.17
  • EPS
  • SNPS 9.62
  • ELV 27.42
  • Revenue
  • SNPS $6,483,438,000.00
  • ELV $174,015,000,000.00
  • Revenue This Year
  • SNPS $7.16
  • ELV N/A
  • Revenue Next Year
  • SNPS $12.52
  • ELV $7.68
  • P/E Ratio
  • SNPS $58.75
  • ELV $14.68
  • Revenue Growth
  • SNPS 26.26
  • ELV 3.20
  • 52 Week Low
  • SNPS $457.52
  • ELV $391.02
  • 52 Week High
  • SNPS $629.38
  • ELV $567.26
  • Technical
  • Relative Strength Index (RSI)
  • SNPS 61.07
  • ELV 34.47
  • Support Level
  • SNPS $515.00
  • ELV $391.02
  • Resistance Level
  • SNPS $567.01
  • ELV $433.38
  • Average True Range (ATR)
  • SNPS 14.84
  • ELV 9.44
  • MACD
  • SNPS 0.73
  • ELV 1.91
  • Stochastic Oscillator
  • SNPS 83.95
  • ELV 27.23

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Share on Social Networks: